| Period | Revenue | Adj. EPS | GAAP EPS | Beat/Miss | NIM |
|---|---|---|---|---|---|
| Q1 2026 (Act.) | $2.60B | $0.83 | $0.14 | +$0.20 ✅ | 3.30% |
| Q2 2026 (Est.) | $3.26B | $0.86–$0.98 | — | Jul 17 📅 | +3–5 bps |
| FY 2026 (Guide) | NII $8.7–8.8B | ~$4.10 | — | Consensus | Expanding |
| Q2 NII Guide | $2.20–$2.25B | — | — | — | — |
| Metric | FITB | Industry Avg | Assessment |
|---|---|---|---|
| P/E (Forward) | 18–25× | 12.2× | Premium ⚠️ |
| Price/Book | ~1.2–1.4× | ~1.0× | Slight Prem. |
| Div. Yield | ~2.8% | ~2.5% | Competitive |
| Market Cap | ~$50.93B | — | Mid-Large Cap |
| Total Assets | ~$300B | — | 9th Largest US Bank |
| Net Charge-Off Guide | 30–40 bps | ~35 bps avg | In-Line |
| NIM Q1 2026 | 3.30% | ~2.9% | Above Avg |
| Analyst/Firm | Rating | Target | Date | Note |
|---|---|---|---|---|
| Truist | Buy | $60 | Jun 24, 2026 | Raised target on upgrades |
| Morgan Stanley | Buy | $67 | Mar 2026 | Highest target; bull case |
| Stephens | Buy | ~$58 | Recent | Avg recent coverage |
| Baird | Buy | ~$58 | Recent | Avg recent coverage |
| Zacks | Buy | — | Jun 2026 | Upgraded to Buy |
| Consensus (24 analysts) | Mod. Buy | $53–$63 | Jun 2026 | Recent avg ~$58.67 |